Portfolio company
Toxometris.ai
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company provides an artificial intelligence platform for predicting chemical toxicity and drug properties for pharmaceutical and biotechnology researchers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Axiom Bio
This company develops artificial intelligence models that predict drug toxicity to help pharmaceutical researchers identify safety risks early in the development process.
Anto Biosciences
This company develops foundation models for microbial communities to predict drug toxicity and efficacy for pharmaceutical and biotechnology researchers.
Drug Discovery
This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.
TANDEMAI
This company provides a platform combining artificial intelligence and physics-based computation with wet lab services for biotech and pharmaceutical drug discovery.
QuantHealth
This company develops an artificial intelligence platform for clinical trial simulation and drug-patient outcome prediction for the pharmaceutical and biotechnology industries.
ScienceMachine
This company develops autonomous artificial intelligence agents to automate biomedical data analysis and research workflows for biotechnology and pharmaceutical organisations.
intoDNA
This company develops an AI-powered platform for detecting and quantifying DNA damage in cells to support pharmaceutical companies with drug development and diagnostics.
Ingenix.ai
This company develops artificial intelligence software for simulating clinical trials and predicting drug efficacy to assist pharmaceutical and biotechnology organisations.
